Vistagen Therapeutics (NASDAQ:VTGN) Faces Muted Market Sentiment as Crucial PALISADE-4 Data Looms
Vistagen Therapeutics Inc VTGN
$0.67
▼ -2.87%
($-0.02)
Open
$0.69
Prev Close
$0.69
Day Range
$0.67 – $0.73
52W Range
$0.43 – $5.14
Market Cap
$28.31M
Beta
0.37
EPS (TTM)
$-1.46
📋 Company Profile
| Industry | Biotechnology |
| Country | US |
| Exchange | NASDAQ NMS - GLOBAL MARKET |
| Currency | USD |
| IPO Date | 2010-10-18 |
| Shares Out. | 41,030,000 |
| Website | vistagen.com/ ↗ |
| Phone | 16505773600 |
Vistagen Therapeutics Inc is a publicly traded company under the ticker symbol VTGN on the NASDAQ NMS - GLOBAL MARKET, operating in the Biotechnology industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
📊 Analyst Ratings
10 analysts (2026-06-01)